Company / PP&E (Net)
Bausch & Lomb Corp PP&E (Net) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.8B
FY2025
5-year range
$1.2B / $1.8B
FY2021-FY2025
Trend
+18.7%
vs FY2024
Sector context
#30 of 135
Health Care
What the data says
Bausch & Lomb Corp's pp&e (net) of $1.8B is higher than 78% of companies in the Health Care sector (FY2025). PP&E (Net) has increased for 4 consecutive years, from $1.2B in FY2021 to $1.8B in FY2025.
Based on SEC 10-K filings.
$1.8B in FY2025 with a 3-year CAGR of +10.7%. Top quartile in the Health Care sector.
Improved from $1.4B to $1.8B over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +10.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 135This company $1.8B Sector average $1.4B
▼
+29.4% above sector average
Key checks
Key Insights
- Bausch & Lomb Corp's pp&e (net) has grown for 4 consecutive years.
- 3-year CAGR of +10.7%, indicating consistent growth.
- In FY2025, pp&e (net) increased 18.7% year-over-year.
- Ranks #30 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.8B | +18.7% |
| FY2024 | $1.5B | +6.8% |
| FY2023 | $1.4B | +6.9% |
| FY2022 | $1.3B | +6.1% |
| FY2021 | $1.2B | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026